BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35475476)

  • 101. SOX2 Expression Does Not Guarantee Cancer Stem Cell-like Characteristics in Lung Adenocarcinoma.
    Bae SH; Lee KY; Han S; Yun CW; Park C; Jang H
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334608
    [TBL] [Abstract][Full Text] [Related]  

  • 102. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response.
    Mirzaei S; Paskeh MDA; Entezari M; Mirmazloomi SR; Hassanpoor A; Aboutalebi M; Rezaei S; Hejazi ES; Kakavand A; Heidari H; Salimimoghadam S; Taheriazam A; Hashemi M; Samarghandian S
    Biomed Pharmacother; 2022 Dec; 156():113860. PubMed ID: 36272267
    [TBL] [Abstract][Full Text] [Related]  

  • 103. USP36 plays an oncogenic role in colorectal cancer cells.
    Luo L; Li Y; Huang R; Li L; Wu C; Zeng Q
    Neoplasma; 2024 Feb; 71(1):13-21. PubMed ID: 38215036
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Downregulation of TEX11 promotes S-Phase progression and proliferation in colorectal cancer cells through the FOXO3a/COP1/c-Jun/p21 axis.
    Zhang X; Hu F; Zhu B; Jiao X; Li Y; Wu S; Ren G; Li J; Xie Q; Pan Y; Li H; Zhao L
    Oncogene; 2022 Nov; 41(47):5133-5145. PubMed ID: 36258021
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures.
    Mokgautsi N; Kuo YC; Huang YJ; Chen CH; Mukhopadhyay D; Wu ATH; Huang HS
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672201
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Isoform-specific effects of transcription factor TCFL5 on the pluripotency-related genes SOX2 and KLF4 in colorectal cancer development.
    Galán-Martínez J; Stamatakis K; Sánchez-Gómez I; Vázquez-Cuesta S; Gironés N; Fresno M
    Mol Oncol; 2022 May; 16(9):1876-1890. PubMed ID: 34623757
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Cytosolic N-terminal formyl-methionine deformylation derives cancer stem cell features and tumor progression.
    Kim D; Lee J; Seok OH; Lee Y; Hwang CS
    Sci Rep; 2024 Jun; 14(1):14900. PubMed ID: 38942903
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Emerging mechanisms progress of colorectal cancer liver metastasis.
    Zhao W; Dai S; Yue L; Xu F; Gu J; Dai X; Qian X
    Front Endocrinol (Lausanne); 2022; 13():1081585. PubMed ID: 36568117
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Stromal WNTer Keeps the Tumor Cold and Drives Metastasis.
    Jackstadt R; Norman JC
    Dev Cell; 2021 Jan; 56(1):3-4. PubMed ID: 33434524
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Lncrna ANGPTL1-3 and its target microRNA-30a exhibit potency as biomarkers for bortezomib response and prognosis in multiple myeloma patients.
    Zhou F; Guo L
    Hematology; 2022 Dec; 27(1):596-602. PubMed ID: 35617291
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Retraction: ANGPTL1 Interacts with Integrin α1β1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.
    Yan Q; Jiang L; Liu M; Yu D; Zhang Y; Li Y; Fang S; Li Y; Zhu YH; Yuan Y; Guan XY
    Cancer Res; 2022 Nov; 82(22):4299. PubMed ID: 36377386
    [No Abstract]   [Full Text] [Related]  

  • 112. Activin and Hepatocyte Growth Factor Promotes Colorectal Cancer Stemness and Metastasis through FOXM1/SOX2/CXCR4 Signaling.
    Peng H; Ye T; Deng L; Yang X; Li Q; Tong J; Guo J
    Gut Liver; 2024 May; 18(3):476-488. PubMed ID: 37458065
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Sequential Treatment with Activin and Hepatocyte Growth Factor Induces FOXM1 to Promote Colorectal Cancer Liver Metastasis.
    Peng H; Ye T; Deng L; Yang X; Jiang Z; Guo J
    Can J Gastroenterol Hepatol; 2022; 2022():8996203. PubMed ID: 36591565
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Comprehensive Analysis of Potential Prognostic Values of ANGPTLs in Colorectal Cancer.
    Zhang Y; Yang X; Liu S; Zhuang Z; Wei M; Deng X; Wang Z
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553482
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Non-alcoholic fatty liver disease and liver secretome.
    Khan MS; Lee C; Kim SG
    Arch Pharm Res; 2022 Dec; 45(12):938-963. PubMed ID: 36441472
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Prognostic Assessment of Oxidative Stress-Related Genes in Colorectal Cancer and New Insights into Tumor Immunity.
    Chen Z; Mei K; Xiao Y; Xiong Y; Long W; Wang Q; Zhong J; Di D; Ge Y; Luo Y; Li Z; Huang Y; Gu R; Wang B
    Oxid Med Cell Longev; 2022; 2022():2518340. PubMed ID: 36299603
    [TBL] [Abstract][Full Text] [Related]  

  • 117. ANGPTL1, Foxo3a-Sox2, and colorectal cancer metastasis.
    Jiang K; Chen H; Ding K
    Clin Sci (Lond); 2022 Sep; 136(18):1367-1370. PubMed ID: 36156125
    [TBL] [Abstract][Full Text] [Related]  

  • 118. ANGPTL1 attenuates cancer migration, invasion, and stemness through regulating FOXO3a-mediated SOX2 expression in colorectal cancer.
    Chang TY; Lan KC; Chiu CY; Sheu ML; Liu SH
    Clin Sci (Lond); 2022 May; 136(9):657-673. PubMed ID: 35475476
    [TBL] [Abstract][Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.